Article Text

Download PDFPDF
Sustained hypothyroidism induced by recombinant alpha interferon in patients with chronic hepatitis C.
  1. P Marcellin,
  2. M Pouteau,
  3. P Renard,
  4. J M Grynblat,
  5. N Colas Linhart,
  6. P Bardet,
  7. B Bok,
  8. J P Benhamou
  1. Services d'Hépatologie, Hôpital Beaujon, Clichy, France.


    Thyroid dysfunction has been reported in patients with malignant disease treated with recombinant alpha interferon. Two cases of hypothyroidism in patients with chronic hepatitis C treated with recombinant alpha interferon are reported. In one patient, interferon induced hypothyroidism in the absence of pre-existing thyroid dysfunction and in the other it aggravated a pre-existing thyroid dysfunction. Both patients developed a severe, sustained hypothyroidism requiring thyroxine treatment for one year or more after stopping alpha interferon. Diagnosis of hypothyroidism during treatment can be difficult because of the common side effects of alpha interferon. Thyroid function should be assessed before and during alpha interferon therapy in patients with chronic hepatitis C.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Linked Articles